These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 7675121)
1. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Hajós M; Gartside SE; Sharp T Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):624-9. PubMed ID: 7675121 [TBL] [Abstract][Full Text] [Related]
2. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182 [TBL] [Abstract][Full Text] [Related]
3. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Hajós M; Hajós-Korcsok E; Sharp T Br J Pharmacol; 1999 Apr; 126(8):1741-50. PubMed ID: 10372816 [TBL] [Abstract][Full Text] [Related]
4. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems. Gartside SE; McQuade R; Sharp T Neuropharmacology; 1997; 36(11-12):1697-703. PubMed ID: 9517441 [TBL] [Abstract][Full Text] [Related]
5. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Gartside SE; Umbers V; Hajós M; Sharp T Br J Pharmacol; 1995 Jul; 115(6):1064-70. PubMed ID: 7582504 [TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors. Hajós M; Gartside SE; Varga V; Sharp T Neuropharmacology; 2003 Jul; 45(1):72-81. PubMed ID: 12814660 [TBL] [Abstract][Full Text] [Related]
7. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Sharp T; Umbers V; Gartside SE Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551 [TBL] [Abstract][Full Text] [Related]
8. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine. Hertel P; Nomikos GG; Svensson TH Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809 [TBL] [Abstract][Full Text] [Related]
9. 5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Arborelius L; Nomikos GG; Grillner P; Hertel P; Höök BB; Hacksell U; Svensson TH Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):157-65. PubMed ID: 7477438 [TBL] [Abstract][Full Text] [Related]
10. In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Boothman L; Raley J; Denk F; Hirani E; Sharp T Br J Pharmacol; 2006 Dec; 149(7):861-9. PubMed ID: 17043669 [TBL] [Abstract][Full Text] [Related]
11. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus. Bermack JE; Haddjeri N; Debonnel G J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555 [TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of chronic paroxetine on 5-HT1A control of dorsal raphe cell firing and 5-HT release. Davidson C; Stamford JA Neuroreport; 1998 Aug; 9(11):2535-8. PubMed ID: 9721928 [TBL] [Abstract][Full Text] [Related]
13. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Béïque JC; de Montigny C; Blier P; Debonnel G Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630 [TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area. Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293 [TBL] [Abstract][Full Text] [Related]
16. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus. Mundey MK; Fletcher A; Marsden CA Neuropharmacology; 1994 Jan; 33(1):61-6. PubMed ID: 8183439 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms. Gartside SE; Umbers V; Sharp T Psychopharmacology (Berl); 1997 Apr; 130(3):261-8. PubMed ID: 9151361 [TBL] [Abstract][Full Text] [Related]
18. In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus. Dudley TE; Dinardo LA; Glass JD J Neurophysiol; 1999 Apr; 81(4):1469-77. PubMed ID: 10200183 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats. Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073 [TBL] [Abstract][Full Text] [Related]
20. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. Gartside SE; Clifford EM; Cowen PJ; Sharp T Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]